An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort
- PMID: 38441716
- DOI: 10.1007/s11136-024-03600-8
An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort
Abstract
Purpose: In this study, we evaluated readability and understandability of nine French-language Patient-Reported Outcome Measures (PROMs) that are currently used in a contemporary longitudinal cohort of breast cancer survivors as part of an effort to improve equity in cancer care and research.
Methods: Readability of PROMs was assessed using the Flesh Reading Ease Score (FRES), the Gunning's Fog Index (FOG), and the FRY graphics. Readability was considered ideal if mean score ≤ 6th-grade level and acceptable if between 6th and 8th grade. Understandability was evaluated using the Patient Education Materials Assessment Tool and defined as ideal if PEMAT ≥ 80%. The Evaluative Linguistic Framework for Questionnaires (ELF-Q) provided additional qualitative elements to assess understandability. Plain-language best practice was met if both readability and understandability were ideal.
Results: None of the 9 PROMs evaluated had ideal readability scores and only 1 had an acceptable score. Understandability ranged from 55% to 91%, and only 3 PROMs had ideal scores. ELF-Q identified points for improvement in several understandability dimensions of the PROMs. None of the instruments met the definition of plain-language best practice.
Conclusion: None of the studied PROMs met the standards of readability and understandability. Future development and translation of PROMs should follow comprehensive linguistic and cultural frameworks to ensure plain-language standards and enhance equitable patient-centered care and research.
Keywords: PROMs; PROs; Patient-reported outcome measures; Readability; Survivorship; Understandability.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
References
-
- Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed
-
- Cancer Statistics Review, 1975–2012 – Previous Version – SEER Cancer Statistics Review. In: SEER. https://seer.cancer.gov/archive/csr/1975_2012/index.html . Accessed 22 Feb 2023.
-
- Ferreira, A. R., Meglio, A. D., Pistilli, B., et al. (2019). Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: A prospective patient-reported outcomes analysis. Annals of Oncology, 30, 1784–1795. https://doi.org/10.1093/annonc/mdz298 - DOI - PubMed
-
- Dumas, A., Vaz Luis, I., Bovagnet, T., et al. (2020). Impact of breast cancer treatment on employment: Results of a multicenter prospective cohort study (CANTO). Journal of Clinical Oncology, 38, 734–743. https://doi.org/10.1200/JCO.19.01726 - DOI - PubMed
-
- Firkins, J., Hansen, L., Driessnack, M., & Dieckmann, N. (2020). Quality of life in “chronic” cancer survivors: A meta-analysis. Journal of Cancer Survivorship, 14, 504–517. https://doi.org/10.1007/s11764-020-00869-9 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
